+Search query
-Structure paper
| Title | A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity. |
|---|---|
| Journal, issue, pages | Nat Commun, Vol. 17, Issue 1, Year 2026 |
| Publish date | Jan 24, 2026 |
Authors | Danton Ivanochko / Kazutoyo Miura / Sophia Hailemariam / Rashmi Ravichandran / Yiting Song / Wei-Chiao Huang / Rianne Stoter / Karina Teelen / Geert-Jan van Gemert / Elizabeth M Leaf / Sidney Chan / Christine Men / Anthony Semesi / Carol Shiu / Randall S MacGill / Carole A Long / Matthijs M Jore / Neil P King / Jonathan F Lovell / Jean-Philippe Julien / ![]() |
| PubMed Abstract | Malaria parasite transmission remains a barrier to elimination since asymptomatic individuals sustain the infectious reservoir. Transmission-blocking vaccine (TBV) candidates targeting Plasmodium ...Malaria parasite transmission remains a barrier to elimination since asymptomatic individuals sustain the infectious reservoir. Transmission-blocking vaccine (TBV) candidates targeting Plasmodium falciparum (Pf) gametocyte surface proteins Pfs230 and Pfs48/45 have shown promise in clinical trials. Several vaccine candidates have been developed for these antigens, yet it is unclear which elicit the most robust and durable transmission-blocking responses. From structure-function relationships of monoclonal antibodies in complex with both antigens, we report the development of a stabilized tandem antigen chimera (STAC), which presents the most potent epitopes from Pfs230 domain 1 (Pfs230-D1) and Pfs48/45 domain 3 (Pfs48/45-D3) in a single construct, while masking non-functional epitopes using an engineered pseudo-native domain disposition. Iterative structure-guided optimization improved antigen yields and stability, while nanoparticle-based multimerization enhanced the functional transmission-reducing activity elicited by the immunogen in female mice. Immunizations with STAC genetically conjugated to self-assembling protein nanoparticles elicited antibodies with potent transmission-reducing activity comparable or superior to the multimerized Pfs230-D1 and Pfs48/45-D3. These findings establish STAC as a promising next-generation TBV candidate to disrupt malaria transmission and accelerate elimination efforts. More broadly, our results support the engineering of highly ordered and stable multi-domain antigens in a single protein as a strategy for the cost-efficient development of multi-component vaccines. |
External links | Nat Commun / PubMed:41580424 / PubMed Central |
| Methods | EM (single particle) / X-ray diffraction |
| Resolution | 1.85 - 3.22 Å |
| Structure data | EMDB-49130, PDB-9n8j: ![]() PDB-9n8i: ![]() PDB-9n8n: |
| Chemicals | ![]() ChemComp-EDO: ![]() ChemComp-CA: ![]() ChemComp-HOH: ![]() ChemComp-PGE: ![]() ChemComp-CL: ![]() ChemComp-PEG: ![]() ChemComp-TRS: ![]() ChemComp-ACT: ![]() ChemComp-CAC: |
| Source |
|
Keywords | IMMUNE SYSTEM / Antibody / Malaria / Pfs230 / Pfs48/45 / structure-based immunogen design / human transmission-blocking antibodies / Malaria vaccine |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links












homo sapiens (human)

Keywords